These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17053437)

  • 1. Peptic ulcer disease.
    Louw JA
    Curr Opin Gastroenterol; 2006 Nov; 22(6):607-11. PubMed ID: 17053437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The appropriate use of proton-pump inhibitor co-therapy with non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors.
    Lanas A
    Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():2-4, 21-4. PubMed ID: 15755265
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; KwiecieĊ„ S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intractable ulcer].
    Yoshida Y; Miyatani H; Tokuyama T; Hirakawa R
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():583-6. PubMed ID: 11979851
    [No Abstract]   [Full Text] [Related]  

  • 7. Peptic ulcer disease: clinically relevant causes and treatments.
    Mynatt RP; Davis GA; Romanelli F
    Orthopedics; 2009 Feb; 32(2):104. PubMed ID: 19301796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of addressing the condition of nonsteroidal anti-inflammatory drug-related gastropathy.
    Cryer B
    Am J Manag Care; 2001 Sep; 7(12 Suppl):S407-11. PubMed ID: 11570034
    [No Abstract]   [Full Text] [Related]  

  • 9. Helicobacter pylori-negative nonsteroidal anti-inflammatory drug-negative ulcer.
    McColl KE
    Gastroenterol Clin North Am; 2009 Jun; 38(2):353-61. PubMed ID: 19446263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
    Cherian PT; Cherian S; Singh P
    Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
    Vakil N
    Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 13. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Steen KS; Lems WF; Dijkmans BA
    Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1649-52. PubMed ID: 10494299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori and non-malignant diseases.
    Shirin H; Leja M; Niv Y
    Helicobacter; 2008 Oct; 13 Suppl 1():23-7. PubMed ID: 18783518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005.
    Hunt RH
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():10-9. PubMed ID: 16303032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression.
    Malfertheiner P; Fass R; Quigley EM; Modlin IM; Malagelada JR; Moss SF; Holtmann G; Goh KL; Katelaris P; Stanghellini V; Talley NJ; Tytgat GN; Wright NA
    Aliment Pharmacol Ther; 2006 Mar; 23(6):683-90. PubMed ID: 16556170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of peptic ulcer disease.
    Louw JA; Marks IN
    Curr Opin Gastroenterol; 1999 Nov; 15(6):497-503. PubMed ID: 17023996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory factors for healing of NSAIDs-induced ulcers].
    Yanaka A
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():559-61. PubMed ID: 11979845
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drugs: who should receive prophylaxis?
    Hawkey CJ
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():59-64. PubMed ID: 15335414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.